Market Overview - A-shares maintained a volatile trend with major indices supported by sectors such as pharmaceuticals, chemicals, and automobiles. The Shenzhen index outperformed the Shanghai index, with the Shanghai Composite Index up 0.08%, Shenzhen Component Index up 0.50%, and ChiNext Index up 0.48% at midday [1] - Hong Kong stocks also saw gains, with the Hang Seng Index up 0.58% and the Hang Seng Tech Index up 0.61% at midday [1] Pharmaceutical Sector - The pharmaceutical sector experienced a surge following the strong debut of Hengrui Medicine on the Hong Kong stock market. Stocks such as Duorui Medicine and Haichen Pharmaceutical hit the 20% limit up, while several others rose over 10% [2][4] - Hengrui Medicine's IPO was priced at HKD 44.05 per share, raising approximately HKD 9.9 billion, marking the largest IPO in the Hong Kong pharmaceutical sector in the past five years. The company plans to allocate about 75% of the funds for R&D, 15% for building new facilities, and 10% for working capital [4] - The aging population is driving demand for healthcare, creating a favorable environment for pharmaceutical investments. The market for consumer healthcare products is expected to grow as the elderly population increases [4][5] Chemical Sector - The chemical sector has been active, with several stocks showing significant gains. Companies like United Chemical and Yanggu Huatai saw increases of over 12% [6] - United Chemical has seen its stock price increase over tenfold, focusing on organic pigments and electronic chemicals, which are in high demand due to their applications in high-tech industries [8] Automotive Sector - The automotive sector showed strong performance, with stocks like Demais hitting the 20% limit up and BYD rising over 4%, reaching a new historical high [9][14] - In May, the retail market for narrow passenger vehicles is estimated to be around 1.85 million units, a year-on-year increase of 8.5%. The penetration rate for new energy vehicles reached approximately 52.9% [13]

Market Overview - The Shanghai Composite Index rose by 0.08%, the Shenzhen Component Index increased by 0.50%, and the ChiNext Index gained 0.48% at midday [1] - The Hong Kong market also saw gains, with the Hang Seng Index up by 0.58% and the Hang Seng Tech Index up by 0.61% [1] Pharmaceutical Sector - The pharmaceutical sector in A-shares experienced a surge following the strong debut of Hengrui Medicine in Hong Kong, with stocks like Duorui Medicine and Haichen Pharmaceutical hitting the 20% limit up [3][5] - Hengrui Medicine's IPO was priced at 44.05 HKD per share, raising approximately 9.9 billion HKD, marking the largest IPO in the Hong Kong pharmaceutical sector in the past five years [5] - The funds raised will primarily be used for R&D (75%), with additional allocations for expanding production facilities (15%) and general corporate purposes (10%) [5] - The aging population is driving demand for healthcare, creating favorable conditions for investment in the pharmaceutical sector, particularly in consumer healthcare products [5][6] Chemical Sector - The chemical sector has shown strong activity, with stocks like United Chemical and Yanggu Huatai seeing significant gains, some even doubling in value [8][10] - United Chemical has increased over tenfold, focusing on organic pigments and electronic chemicals, which are in high demand due to their applications in high-tech industries [10] Automotive Sector - The automotive sector is performing robustly, with stocks like Demais and Hanma Technology reaching their daily limit up [12] - BYD, a leader in the new energy vehicle market, has seen its stock price rise over 4%, continuing to set historical highs [12][16] - In May, the retail market for narrow passenger vehicles is estimated to be around 1.85 million units, reflecting an 8.5% year-on-year increase, with new energy vehicles accounting for approximately 52.9% of sales [16]